SOM Biotech will attend the “Chiba Global Healthcare Business Forum 2021” on February 3rd – 4th, which will take place digitally due to the pandemic situation.

Organized by the Japanese External Trade Association, the Chiba Healthcare Business Forum attracts the most advanced academic and research institutions as well as healthcare and life science companies worldwide to present their latest research projects and business developments.

Maria Zimina, Business Development Manager of SOM Biotech highlights: “The Chiba Healthcare Business Forum is a unique event for companies of the life science and healthcare sectors. We look forward to presenting the advantages and effectiveness of our proprietary AI-based drug discovery platform and to exploring partnerships with innovative pharmaceutical companies and research institutions. The high efficacy and versatility of our pioneering technology have allowed SOM Biotech not only to build a robust drug development pipeline but also to become a fundamental ally for those pharmaceutical companies that want to rescue and reposition their own drugs to increase their lifecycle and generate additional value.

Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Rethinking Alzheimer’s clinical trials...

by Fundació Clínic per a la Recerca Biomèdica

A paper published in Alzheimer’s & Dementia: The Journal of the Alzh...

Photos Stream